We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Postoperative Sleep Quality in Patients Undergoing Thoracic Surgery With Different Types of Anesthesia Management

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01725607
First Posted: November 14, 2012
Last Update Posted: July 8, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Wen-fei Tan, China Medical University, China
  Purpose
We designed a study to determine whether a single dose of dexmedetomidine or thoracic epidural anesthesia combined with general anesthesia would provide hemodynamic stability, reduce stress hormone responses, inhibit inflammatory cytokine secretion, and improve sleep quality in patients after thoracic surgery.

Condition Intervention Phase
General Anesthesia, Thoracic Epidural Anesthesia Drug: general anesthesia combined with dexmedetomidine infusion Procedure: general anesthesia combined with TEA Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Postoperative Sleep Quality in Patients Undergoing Thoracic Surgery With Different Types of Anesthesia Management

Resource links provided by NLM:


Further study details as provided by Wen-fei Tan, China Medical University, China:

Primary Outcome Measures:
  • inflammatory cytokine secretion and postoperative sleep quality [ Time Frame: immediately before anesthesia (T1), 5 min after endotracheal intubation (T2), immediately after incision (T3), 5 min after OLV initiation (T4), 5 min after double-lung ventilation initiation (T5), and immediately after extubation (T6) ]
    Primary outcomes were inflammatory cytokine secretion and postoperative sleep quality, which was measured with the BIS data on first and second postoperative nights.


Secondary Outcome Measures:
  • amine secretion during the surgical period and hemodynamic stability [ Time Frame: immediately before anesthesia (T1), 5 min after endotracheal intubation (T2), immediately after incision (T3), 5 min after OLV initiation (T4), 5 min after double-lung ventilation initiation (T5), and immediately after extubation (T6) ]
    amine (epinephrine and norepinephrine) secretion during the surgical period and hemodynamic stability


Enrollment: 219
Study Start Date: January 2013
Study Completion Date: March 2014
Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: the control group (Group C)
general anesthesia
Experimental: general anesthesia combined with dexmedetomidine infusion
general anesthesia combined with 1 μg/kg dexmedetomidine infusion after induction (Group D)
Drug: general anesthesia combined with dexmedetomidine infusion
general anesthesia combined with 1 μg/kg dexmedetomidine infusion after induction (Group D)
Experimental: general anesthesia combined with TEA
general anesthesia combined with TEA (Group E)
Procedure: general anesthesia combined with TEA
general anesthesia combined with TEA (Group E)

Detailed Description:
We designed a prospective, single-blinded, randomized, and controlled study to determine whether a single dose of dexmedetomidine or thoracic epidural anesthesia combined with general anesthesia would provide hemodynamic stability, reduce stress hormone responses, inhibit inflammatory cytokine secretion, and improve sleep quality in patients after thoracic surgery.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • lung surgery
  • one-lung ventilation.

Exclusion Criteria:

  • body mass index exceeding 30 kg/m2,
  • autonomic dysfunction,
  • cardiovascular disease,
  • neurological or psychiatric diseases
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01725607


Locations
China, Liaoning
Department of Anesthesiology, the First Hospital of China Medical University
Shenyang, Liaoning, China, 110001
Sponsors and Collaborators
China Medical University, China
Investigators
Study Chair: Hong Ma, M.D.,PhD. Dept. of Anesthesiology, the First Hospital of CMU
  More Information

Responsible Party: Wen-fei Tan, associate professor, China Medical University, China
ClinicalTrials.gov Identifier: NCT01725607     History of Changes
Other Study ID Numbers: 20121101
First Submitted: November 3, 2012
First Posted: November 14, 2012
Last Update Posted: July 8, 2015
Last Verified: October 2013

Keywords provided by Wen-fei Tan, China Medical University, China:
dexmedetomidine, thoracic epidural anesthesia

Additional relevant MeSH terms:
Anesthetics
Dexmedetomidine
Central Nervous System Depressants
Physiological Effects of Drugs
Hypnotics and Sedatives
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action